|
1
|
Sutton MG and Sharpe N: Left ventricular
remodeling after myocardial infarction: pathophysiology and
therapy. Circulation. 101:2981–2988. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frangogiannis NG, Smith CW and Entman ML:
The inflammatory response in myocardial infarction. Cardiovasc Res.
53:31–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dorn GW 2nd: Apoptotic and non-apoptotic
programmed cardiomyocyte death in ventricular remodelling.
Cardiovasc Res. 1:465–473. 2009.PubMed/NCBI
|
|
4
|
Frantz S, Bauersachs J and Ertl G:
Post-infarct remodelling: contribution of wound healing and
inflammation. Cardiovasc Res. 81:474–481. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nian M, Lee P, Khaper N and Liu P:
Inflammatory cytokines and postmyocardial infarction remodeling.
Circ Res. 94:1543–1553. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koyama M, Kelly TR and Watanabe KA: Novel
type of potential anticancer agents derived from chrysophanol and
emodin. Some structure-activity relationship studies. J Med Chem.
31:283–284. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun M, Dawood F, Wen WH, Chen M, Dixon I,
Kirshenbaum LA and Liu PP: Excessive tumor necrosis factor
activation after infarction contributes to susceptibility of
myocardial rupture and left ventricular dysfunction. Circulation.
110:3221–3228. 2004.
|
|
8
|
Baldi A, Abbate A, Bussani R, Patti G,
Melfi R, Angelini A, Dobrina A, Rossiello R, Silvestri F, Baldi F
and Di Sciascio G: Apoptosis and post-infarction left ventricular
remodeling. J Mol Cell Cardiol. 34:165–174. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Palojoki E, Saraste A, Eriksson A, Pulkki
K, Kallajoki M, Voipio-Pulkki LM and Tikkanen I: Cardiomyocyte
apoptosis and ventricular remodeling after myocardial infarction in
rats. Am J Physiol Heart Circ Physiol. 280:H2726–H2731.
2001.PubMed/NCBI
|
|
10
|
Yeh CH, Chen TP, Wu YC, Lin YM and Jing
Lin P: Inhibition of NFkappaB activation with curcumin attenuates
plasma inflammatory cytokines surge and cardiomyocytic apoptosis
following cardiac ischemia/reperfusion. J Surg Res. 125:109–116.
2005. View Article : Google Scholar
|
|
11
|
Yeh CH, Chen TP, Lee CH, Wu YC, Lin YM and
Lin PJ: Cardiomyocytic apoptosis following global cardiac ischemia
and reperfusion can be attenuated by peroxisome
proliferator-activated receptor alpha but not gamma activators.
Shock. 26:262–270. 2006. View Article : Google Scholar
|
|
12
|
Wang M, Tsai BM, Reiger KM, Brown JW and
Meldrum DR: 17-beta-Estradiol decreases p38 MAPK-mediated
myocardial inflammation and dysfunction following acute ischemia. J
Mol Cell Cardiol. 40:202–212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kopp EB and Ghosh S: NF-kappa B and rel
proteins in innate immunity. Adv Immunol. 58:1–27. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kanno T, Franzoso G and Siebenlist U:
Human T-cell leukemia virus type I Tax-protein-mediated activation
of NF-kappa B from p100 (NF-kappa B2)-inhibited cytoplasmic
reservoirs. Proc Natl Acad Sci USA. 91:12634–12638. 1994.
View Article : Google Scholar
|
|
15
|
Onai Y, Suzuki J, Maejima Y, Haraguchi G,
Muto S, Itai A and Isobe M: Inhibition of NF-{kappa}B improves left
ventricular remodeling and cardiac dysfunction after myocardial
infarction. Am J Physiol Heart Circ Physiol. 292:H530–H538. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Karppi J, Kurl S, Nurmi T, Rissanen TH,
Pukkala E and Nyyssönen K: Serum lycopene and the risk of cancer:
the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. Ann
Epidemiol. 19:512–518. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Riccioni G, Mancini B, Di Ilio E,
Bucciarelli T and D’Orazio N: Protective effect of lycopene in
cardiovascular disease. Eur Rev Med Pharmacol Sci. 12:183–190.
2008.PubMed/NCBI
|
|
18
|
Parvin R and Akhter N: Protective effect
of tomato against adrenaline-induced myocardial infarction in rats.
Bangladesh Med Res Counc Bull. 34:104–108. 2008.PubMed/NCBI
|
|
19
|
Upaganlawar A, Gandhi H and Balaraman R:
Effect of vitamin E alone and in combination with lycopene on
biochemical and histopathological alterations in
isoproterenol-induced myocardial infarction in rats. J Pharmacol
Pharmacother. 1:24–31. 2010. View Article : Google Scholar
|
|
20
|
Simone RE, Russo M, Catalano A, Monego G,
Froehlich K, Boehm V and Palozza P: Lycopene inhibits
NF-κB-mediated IL-8 expression and changes redox and PPARγ
signalling in cigarette smoke-stimulated macrophages. PLoS One.
6:e196522011.
|
|
21
|
Gouranton E, Thabuis C, Riollet C,
Malezet-Desmoulins C, El Yazidi C, Amiot MJ, Borel P and Landrier
JF: Lycopene inhibits proinflammatory cytokine and chemokine
expression in adipose tissue. J Nutr Biochem. 22:642–648. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rajadurai M and Stanely Mainzen Prince P:
Preventive effect of naringin on cardiac markers,
electrocardiographic patterns and lysosomal hydrolases in normal
and isoproterenol-induced myocardial infarction in Wistar rats.
Toxicology. 230:178–188. 2007. View Article : Google Scholar
|
|
23
|
Lujan HL and DiCarlo SE: Mimicking the
endogenous current of injury improves post-infarct cardiac
remodeling. Med Hypotheses. 81:521–523. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meloni M, Marchetti M, Garner K,
Littlejohns B, Sala-Newby G, Xenophontos N, Floris I, Suleiman MS,
Madeddu P, Caporali A and Emanueli C: Local inhibition of
microRNA-24 improves reparative angiogenesis and left ventricle
remodeling and function in mice with myocardial infarction. Mol
Ther. 21:1390–1402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanno Y, Watanabe R, Zempo H, Ogawa M,
Suzuki J and Isobe M: Chlorogenic acid attenuates ventricular
remodeling after myocardial infarction in mice. Int Heart J.
54:176–180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lei J, Xue S, Wu W, Zhou S, Zhang Y, Yuan
G and Wang J: Sdc1 overexpression inhibits the p38 MAPK pathway and
lessens fibrotic ventricular remodeling in MI rats. Inflammation.
36:603–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morgia G, Cimino S, Favilla V, Russo GI,
Squadrito F, Mucciardi G, Masieri L, Minutoli L, Grosso G and
Castelli T: Effects of Serenoa repens, selenium and lycopene
(Profluss®) on chronic inflammation associated with
benign prostatic hyperplasia: results of ‘FLOG’ (Flogosis and
Profluss in Prostatic and Genital Disease), a multicentre Italian
study. Int Braz J Urol. 39:214–221. 2013.
|
|
28
|
Renju GL, Muraleedhara Kurup G and Saritha
Kumari CH: Anti-inflammatory activity of lycopene isolated from
Chlorella marina on type II collagen induced arthritis in
Sprague Dawley rats. Immunopharmacol Immunotoxicol. 35:282–291.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hadad N and Levy R: The synergistic
anti-inflammatory effects of lycopene, lutein, β-carotene and
carnosic acid combinations via redox-based inhibition of NF-κB
signaling. Free Radic Biol Med. 53:1381–1391. 2012.PubMed/NCBI
|
|
30
|
Abbate A and Narula J: Role of apoptosis
in adverse ventricular remodeling. Heart Fail Clin. 8:79–86. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singh SS and Kang PM: Mechanisms and
inhibitors of apoptosis in cardiovascular diseases. Curr Pharm Des.
17:1783–1793. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sinha K, Das J, Pal PB and Sil PC:
Oxidative stress: the mitochondria-dependent and
mitochondria-independent pathways of apoptosis. Arch Toxicol.
87:1157–1180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Delmas D, Solary E and Latruffe N:
Resveratrol, a phytochemical inducer of multiple cell death
pathways: apoptosis, autophagy and mitotic catastrophe. Curr Med
Chem. 18:1100–1121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
MacKenzie SH and Clark AC: Death by
caspase dimerization. Adv Exp Med Biol. 747:55–73. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moorjani N, Westaby S, Narula J, Catarino
PA, Brittin R, Kemp TJ, Narula N and Sugden PH: Effects of left
ventricular volume overload on mitochondrial and
death-receptor-mediated apoptotic pathways in the transition to
heart failure. Am J Cardiol. 103:1261–1268. 2009.PubMed/NCBI
|
|
36
|
Satoh M, Minami Y, Takahashi Y and
Nakamura M: Immune modulation: role of the inflammatory cytokine
cascade in the failing human heart. Curr Heart Fail Rep. 5:69–74.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao Y, Li T, Wu C, Bittle GJ, Chen S, Wu
ZJ and Griffith BP: Pim-1 mediated signaling during the process of
cardiac remodeling following myocardial infarction in ovine hearts.
J Mol Cell Cardiol. 63:89–97. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Echtermeyer F, Harendza T, Hubrich S,
Lorenz A, Herzog C, Mueller M, Schmitz M, Grund A, Larmann J,
Stypmann J, Schieffer B, Lichtinghagen R, Hilfiker-Kleiner D,
Wollert KC, Heineke J and Theilmeier G: Syndecan-4 signalling
inhibits apoptosis and controls NFAT activity during myocardial
damage and remodelling. Cardiovasc Res. 92:123–131. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer.
12:862013.
|
|
40
|
González A, Ravassa S, Beaumont J, López B
and Díez J: New targets to treat the structural remodeling of the
myocardium. J Am Coll Cardiol. 58:1833–1843. 2011.PubMed/NCBI
|
|
41
|
Gordon JW, Shaw JA and Kirshenbaum LA:
Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ
Res. 108:1122–1132. 2011.
|
